Check out GMCR stock charts. When GMCR SP dropped from $100 to $20 after a famous hedge fund announced short position, do you think long should be sad or happy? The best long could do was to add additional shares, and waited for SP to go back above $100 after company's earning slapped the hedge fund's criticism of the company.
It should post more company related news in English format. For example, sohu formed a new subsidiary recently: Souyidai, and it's collaberated with focus.cn to offer loan for mortgage downpayment.
That's true. Each year I got a tiny restricted stocks vested in my company (it's most the most common stock grants in tech industry), and my company automatically sells a portion of the grant to cover tax. The reason is vested restricted stock is treated as ordinary income, so company has the obligation to deduct tax from it.
Agreed. When you see people use the warning label as argument against KERX, you already know their agenda. Even I can understand what this warning label means, and you said those well-trained specialists get scared away by this label?
I bought a dell high-end laptop last year with windows 8, and really regretted. The machine slowed down significantly after a few days of use. Reinstalled the OS many times, called dell customer support and couldn't find any issue (all diagnostic run results were ok). The point I want to make is: for most people, cloud (i.e, chromebook type) based computer is the future, no more hassle of dealing with all kinds of computer problems, OS updates, virus, etc.
I expect NVDA to double in a year, if NVDA can continue its momentum of revenue growth. We need some real number to change wall street's sentiment.
Don't know why people make such a big deal about the warning label. It's logical for FDA to remind doctors to monitor iron level, and reduce IV iron if necessary. I just don't see any problem for Keryx's sales team to pinch this as an advantage of this drug to the doctors.
Not sure if Nvidia will ever file a lawsuit against Apple, as Apple is a big customer of Nvidia. More likely, Nvidia will talk nicely and secretly with Apple once it wins the legal fight against Qualcomm/Samsung.
I think it all depends on Al's willingness to sell the company. For SNY, it makes sense to acquire MNKD as it knows Afrezza will become a blockbuster, and it can also better utilize the value of the technosphere plateform.
This rumor might make some sense if Al plans to move on to his next adventure, like the AMF's newly found company.
It's great news for NVDA. Time to cross $20?
The new website seems focusing on promoting the technosphere plateform for third party use with potential application listed as:
Pulmonary arterial hypertension
First you need to get the P-II result peer reviewed to show FDA that it merits a P-III clinical study. FDA will not review their P-II result.
Secondly, I guess Dr. Kim has no rush to start VGX-3100 P-III urgently. P-III will burn a lot of money and INO has only about $100m on hands, while working on multiple drug candidates in parallel. It needs sometime to secure funding (partners, Roche milestone payments, etc). Otherwise, INO may be forced to raise more capital which may not be favorable. As Dr. Kim said about last secondary offering, you'd like to raise capital when you don't need them so you can get favorable term.
That's my plan also. My prediction is 2 bagger in 2 to 3 years, still not too bad.
what's the problem? Sonofi has to feed over 30K representatives doing the selling work, while Mannkind only needs to support a few hundred manufacturing workers. In addition, the upfront payment + milestone payment covers about half of Afrezza's total development expense, not too bad.
That's what I thougt too. It would be very tempting for Apple to get rid of Intel in their products. Then they can have unified CPU across all product lines, and likely sharing on OS design for PC/Tablet/Phones.